Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
This paper documents the process by which we, through gene and miRNA expression profiling of the same samples of head and neck squamous cell carcinomas (HNSCC) and an integrative miRNA-mRNA expression analysis, were able to identify candidate biomarkers of progression-free survival (PFS) in patients...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-01-01
|
Series: | Genes |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4425/8/1/35 |
id |
doaj-0bf15f5b99204a44b38c601d00c03486 |
---|---|
record_format |
Article |
spelling |
doaj-0bf15f5b99204a44b38c601d00c034862020-11-24T21:56:02ZengMDPI AGGenes2073-44252017-01-01813510.3390/genes8010035genes8010035Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell CancerLoris De Cecco0Marco Giannoccaro1Edoardo Marchesi2Paolo Bossi3Federica Favales4Laura D. Locati5Lisa Licitra6Silvana Pilotti7Silvana Canevari8Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyFunctional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyFunctional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyHead and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyHead and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyHead and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyHead and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyLaboratory of Experimental Molecular Pathology, Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyFunctional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, ItalyThis paper documents the process by which we, through gene and miRNA expression profiling of the same samples of head and neck squamous cell carcinomas (HNSCC) and an integrative miRNA-mRNA expression analysis, were able to identify candidate biomarkers of progression-free survival (PFS) in patients treated with cetuximab-based approaches. Through sparse partial least square–discriminant analysis (sPLS-DA) and supervised analysis, 36 miRNAs were identified in two components that clearly separated long- and short-PFS patients. Gene set enrichment analysis identified a significant correlation between the miRNA first-component and EGFR signaling, keratinocyte differentiation, and p53. Another significant correlation was identified between the second component and RAS, NOTCH, immune/inflammatory response, epithelial–mesenchymal transition (EMT), and angiogenesis pathways. Regularized canonical correlation analysis of sPLS-DA miRNA and gene data combined with the MAGIA2 web-tool highlighted 16 miRNAs and 84 genes that were interconnected in a total of 245 interactions. After feature selection by a smoothed t-statistic support vector machine, we identified three miRNAs and five genes in the miRNA-gene network whose expression result was the most relevant in predicting PFS (Area Under the Curve, AUC = 0.992). Overall, using a well-defined clinical setting and up-to-date bioinformatics tools, we are able to give the proof of principle that an integrative miRNA-mRNA expression could greatly contribute to the refinement of the biology behind a predictive model.http://www.mdpi.com/2073-4425/8/1/35miRNAmicroarrayhead and neck squamous cell carcinomas (HNSCC)cetuximabdrug sensitivity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Loris De Cecco Marco Giannoccaro Edoardo Marchesi Paolo Bossi Federica Favales Laura D. Locati Lisa Licitra Silvana Pilotti Silvana Canevari |
spellingShingle |
Loris De Cecco Marco Giannoccaro Edoardo Marchesi Paolo Bossi Federica Favales Laura D. Locati Lisa Licitra Silvana Pilotti Silvana Canevari Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer Genes miRNA microarray head and neck squamous cell carcinomas (HNSCC) cetuximab drug sensitivity |
author_facet |
Loris De Cecco Marco Giannoccaro Edoardo Marchesi Paolo Bossi Federica Favales Laura D. Locati Lisa Licitra Silvana Pilotti Silvana Canevari |
author_sort |
Loris De Cecco |
title |
Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer |
title_short |
Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer |
title_full |
Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer |
title_fullStr |
Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer |
title_full_unstemmed |
Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer |
title_sort |
integrative mirna-gene expression analysis enables refinement of associated biology and prediction of response to cetuximab in head and neck squamous cell cancer |
publisher |
MDPI AG |
series |
Genes |
issn |
2073-4425 |
publishDate |
2017-01-01 |
description |
This paper documents the process by which we, through gene and miRNA expression profiling of the same samples of head and neck squamous cell carcinomas (HNSCC) and an integrative miRNA-mRNA expression analysis, were able to identify candidate biomarkers of progression-free survival (PFS) in patients treated with cetuximab-based approaches. Through sparse partial least square–discriminant analysis (sPLS-DA) and supervised analysis, 36 miRNAs were identified in two components that clearly separated long- and short-PFS patients. Gene set enrichment analysis identified a significant correlation between the miRNA first-component and EGFR signaling, keratinocyte differentiation, and p53. Another significant correlation was identified between the second component and RAS, NOTCH, immune/inflammatory response, epithelial–mesenchymal transition (EMT), and angiogenesis pathways. Regularized canonical correlation analysis of sPLS-DA miRNA and gene data combined with the MAGIA2 web-tool highlighted 16 miRNAs and 84 genes that were interconnected in a total of 245 interactions. After feature selection by a smoothed t-statistic support vector machine, we identified three miRNAs and five genes in the miRNA-gene network whose expression result was the most relevant in predicting PFS (Area Under the Curve, AUC = 0.992). Overall, using a well-defined clinical setting and up-to-date bioinformatics tools, we are able to give the proof of principle that an integrative miRNA-mRNA expression could greatly contribute to the refinement of the biology behind a predictive model. |
topic |
miRNA microarray head and neck squamous cell carcinomas (HNSCC) cetuximab drug sensitivity |
url |
http://www.mdpi.com/2073-4425/8/1/35 |
work_keys_str_mv |
AT lorisdececco integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer AT marcogiannoccaro integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer AT edoardomarchesi integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer AT paolobossi integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer AT federicafavales integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer AT lauradlocati integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer AT lisalicitra integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer AT silvanapilotti integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer AT silvanacanevari integrativemirnageneexpressionanalysisenablesrefinementofassociatedbiologyandpredictionofresponsetocetuximabinheadandnecksquamouscellcancer |
_version_ |
1725859958182903808 |